Frequently Asked Questions

Get answers to common questions about Semaglutide 1.5mg (Weekly injections X 4).

Eligibility is determined during a medical consultation, reviewing medical history, current medications, and prior tolerance of semaglutide doses. We assess contraindications like pregnancy, pancreatitis history, or certain thyroid conditions before approving the four-week 1.5mg protocol.

Common side effects include nausea, constipation, diarrhea, and mild abdominal discomfort. These often lessen over time. Serious but rare reactions require immediate medical attention; our team monitors symptoms and adjusts care to minimize adverse events.

Individual results vary; many patients experience noticeable weight reduction within four weeks, often several pounds. Success depends on diet, activity, metabolism, and adherence. We set realistic expectations and track progress to inform ongoing treatment decisions.

Yes. We perform baseline labs and periodic monitoring to assess metabolic markers, liver and kidney function, and overall safety. Weekly check-ins allow us to evaluate side effects and adjust dosing or provide supportive care as needed.

Administered as once-weekly subcutaneous injections, provided in-clinic by our trained staff or taught for safe at-home use. Each injection follows a clinical check-in to review symptoms, technique, and any dose-related adjustments.

Combination may be appropriate selectively; we evaluate interactions, safety, and redundancy. Prescription medications or supplements require disclosure so we can design a coordinated plan that avoids contraindications and maximizes complementary benefits.